Jazz Pharmaceuticals PLC (JAZZ)

Pretax margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Earnings before tax but after interest (EBT) (ttm)	US$ in thousands	470,351	398,658	297,369	241,226	297,929	-103,590	-263,238	-324,008	-372,784	-77,621	-85,125	-242,199	-112,838	76,797	312,571	620,083	275,095	171,057	117,126	129,790
Revenue (ttm)	US$ in thousands	4,068,943	3,992,713	3,909,883	3,843,380	3,834,209	3,794,392	3,762,904	3,738,465	3,659,374	3,583,982	3,481,445	3,300,378	3,094,238	2,863,024	2,625,797	2,436,422	2,363,567	2,279,790	2,216,604	2,188,301
Pretax margin		11.56%	9.98%	7.61%	6.28%	7.77%	-2.73%	-7.00%	-8.67%	-10.19%	-2.17%	-2.45%	-7.34%	-3.65%	2.68%	11.90%	25.45%	11.64%	7.50%	5.28%	5.93%

December 31, 2024 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $470,351K ÷ $4,068,943K
= 11.56%

The pretax margin for Jazz Pharmaceuticals PLC has shown fluctuations over the analyzed period. It started relatively stable in 2020, ranging from 5.28% to 11.64%. However, significant volatility was observed in the following quarters.

The pretax margin improved notably in the first quarter of 2021, reaching 25.45%, but displayed a sharp decline in the subsequent quarter to 11.90%. This trend continued with negative pretax margins observed in the latter half of 2021 and the first half of 2022.

From the second half of 2022 onwards, the company managed to recover its pretax margin, showing positive figures. By December 2024, the pretax margin had improved to 11.56%.

Overall, the pretax margin of Jazz Pharmaceuticals PLC exhibits a roller-coaster pattern, with both highs and lows. It is essential for stakeholders to delve deeper into the financial performance of the company during periods of negative margins to understand the underlying factors causing these fluctuations.